KR870006898A - 신장염 치료제 - Google Patents

신장염 치료제 Download PDF

Info

Publication number
KR870006898A
KR870006898A KR870000136A KR870000136A KR870006898A KR 870006898 A KR870006898 A KR 870006898A KR 870000136 A KR870000136 A KR 870000136A KR 870000136 A KR870000136 A KR 870000136A KR 870006898 A KR870006898 A KR 870006898A
Authority
KR
South Korea
Prior art keywords
group
carbon atoms
nephritis
treatment
substituted
Prior art date
Application number
KR870000136A
Other languages
English (en)
Inventor
미쭈 다까 다까미
Original Assignee
수주끼 다다시
다이이찌 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 수주끼 다다시, 다이이찌 세이야꾸 가부시끼가이샤 filed Critical 수주끼 다다시
Publication of KR870006898A publication Critical patent/KR870006898A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Reproductive Health (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음.

Description

신장염 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 활성 성분으로서 하나 이상의 하기 일반식(I)의 이미다조퀴나졸린 화합물 또는 이의 염을 함유하는 신장염의 예방 및 치료용 제제.
    상기식에서, R1은 각 알킬 잔기의 탄소수가 1 내지 6인 디알킬아미노그룹, 또는 비치환되거나 치환된 사이클릭 아미노그룹이고, R2는 수소원자, 할로겐 원자, 탄소수 1 내지 6의 알킬 그룹 또는 탄소수 1 내지 6의 알콕시 그룹이다.
  2. 제1항에 있어서, 이미다조퀴나졸린 화합물이 7-피폐리디노-1,2,3,5-테트라하이드로이미다조-[[2,1-b]퀴나졸린-2-온 디하이드로클로라이드인 신장염의 예방 및 치료용 제제.
  3. 제1항에 있어서, 비치환되거나 치환된 사이클릭아미노 그룹이 탄소수 1 내지 6의 알킬 그룹 1 또는 2개로 치환될 수 있는 1-피롤리디닐 그룹, 1-피페리디닐 그룹, 1-피페라지닐 그룹 또는 모노폴리닐 그룹인 신장염의 예방 및 치료용 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR870000136A 1986-01-10 1987-01-10 신장염 치료제 KR870006898A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP301986 1986-01-10
JP3019 1986-01-10

Publications (1)

Publication Number Publication Date
KR870006898A true KR870006898A (ko) 1987-08-13

Family

ID=11545619

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870000136A KR870006898A (ko) 1986-01-10 1987-01-10 신장염 치료제

Country Status (7)

Country Link
US (1) US4766126A (ko)
EP (1) EP0230234B1 (ko)
JP (1) JP2525787B2 (ko)
KR (1) KR870006898A (ko)
AT (1) ATE64095T1 (ko)
DE (1) DE3770481D1 (ko)
PH (1) PH23966A (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU665207B2 (en) * 1991-07-29 1995-12-21 Warner-Lambert Company Quinazoline derivatives as acetylcholinesterase inhibitors
US5707621A (en) * 1994-08-31 1998-01-13 Chugai Pharmaceutical Co., Ltd. Supression of nephritis-induced protein excretion by anti-IL-8

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物

Also Published As

Publication number Publication date
JPS62252724A (ja) 1987-11-04
PH23966A (en) 1990-01-23
US4766126A (en) 1988-08-23
ATE64095T1 (de) 1991-06-15
JP2525787B2 (ja) 1996-08-21
EP0230234A1 (en) 1987-07-29
DE3770481D1 (de) 1991-07-11
EP0230234B1 (en) 1991-06-05

Similar Documents

Publication Publication Date Title
DE3683823D1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
HU895609D0 (en) Process for the preparation of novel 1,4-diazepine derivatives and pharmaceutical compositions containing such compounds
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
ES2000346A6 (es) Un procedimiento para la preparacion de derivados de distamicina
MY101614A (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
ATE35137T1 (de) Thieno(2,3-d)pyrimidin-derivate und deren salze.
KR960007592A (ko) 신규한 피롤로카바졸
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
DE3852107D1 (de) Bestimmte 3-substituierte 2-alkyl-benzofuran-derivate.
BR9913183A (pt) Composto, uso do mesmo, processo para prepará-lo, processo para tratar um indivìduo humano ou animal, e, composição farmacêutica
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
ZA889023B (en) 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them
DK624989A (da) Makrolidforbindelser
KR870006898A (ko) 신장염 치료제
RU94046379A (ru) Новые производные пиперазинил-бис (алкиламино)пиримидинов
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ATE74138T1 (de) Heptanoyl-glu-asp-ala-amino-saeureimmunstimulanten.
MX9206930A (es) Nuevos compuestos
DE3762621D1 (de) Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.
KR900006316A (ko) 벤조 헤테로 고리화합물 및 그 제조방법
ES8206537A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
DK0420224T3 (da) Anthihepatopatisk middel
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
ATE58141T1 (de) 1-hydroxy-5-oxo-5h-pyrido(3,2-a>-phenoxazin-3carbons|ureester.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application